The importance of identifying and treating depression in HIV infected, pregnant women: a review

Journal of Psychosomatic Obstetrics and Gynaecology
Christina PsarosErika Aaron

Abstract

Women make up approximately half of all HIV infections worldwide. A substantial number of women living with HIV in the United States are of childbearing age and many of these women will become pregnant each year. These women must navigate the complexities of two health concerns (HIV infection and pregnancy) and the complexities of two health care provision systems (obstetrics and infectious disease). The goal of HIV treatment during pregnancy is to optimize health of the mother and minimize risk of vertical transmission. To realize these goals, high levels of adherence to antiretroviral therapy (ART) and periodic contact with medical professionals are required. Depression is not uncommon in pregnant women and has been identified as a robust predictor of non-adherence to ART and implicated in difficulty utilizing prenatal care. The purpose of the current article is to review evidence in support of diagnosis and treatment, when appropriate, of unipolar depression in HIV positive, pregnant women in developed nations. The article begins by defining the scope of the problem. Assessment and treatment options are discussed, followed by suggestions for future research.

References

Apr 1, 1989·Journal of Consulting and Clinical Psychology·I H GotlibN I Cordy
Apr 1, 1983·Scandinavian Journal of Work, Environment & Health·K KurppaT Nurminen
Jan 1, 1983·Social Work in Health Care·K JoyceY Sorokin
Mar 13, 1993·Lancet·M T SchechterM V O'Shaughnessy
Aug 11, 1998·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·J A KellyF R Bloom
Nov 30, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·R H KellyD F Zatzick
Apr 13, 2000·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·S L CatzT L McAuliffe
Jun 3, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·S Low-BeerJ S Montaner
May 10, 2001·JAMA : the Journal of the American Medical Association·L MandelbrotUNKNOWN Agence Nationale de Recherches sur le SIDA (ANRS) 075 Study Group
May 1, 2001·The American Journal of Psychiatry·J A Ciesla, J E Roberts
May 12, 2001·American Journal of Obstetrics and Gynecology·H MinkoffA Stek
Sep 26, 2001·Nursing Research·C T Beck
Oct 9, 2001·HIV Clinical Trials·UNKNOWN Panel on Clinical Practices for Treatment of HIV Infection
Nov 16, 2001·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·UNKNOWN Panel on Clinical Practices for Treatment of HIV infection
May 1, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ellen R CooperUNKNOWN Women and Infants' Transmission Study Group
May 3, 2002·The American Journal of Psychiatry·Mary F MorrisonDwight L Evans
Jun 6, 2002·Journal of General Internal Medicine·Julia H ArnstenEllie E Schoenbaum
Jun 14, 2003·Journal of Women's Health·Sheila M MarcusKristen L Barry
Sep 27, 2003·AIDS Care·D L JonesS M Weiss
Apr 7, 2004·Psychiatric Services : a Journal of the American Psychiatric Association·Megan V SmithKimberly A Yonkers
May 6, 2004·Maternal and Child Health Journal·Tracey E WilsonLinda J Koenig
Jul 6, 2004·General Hospital Psychiatry·Emma RobertsonDonna E Stewart
Aug 27, 2004·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·Ashwin A PatkarPrakash S Masand
Nov 18, 2004·Journal of Affective Disorders·Rachel ManberChristine M Blasey
Jan 7, 2005·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Lori BonariGideon Koren
Mar 15, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Lourdes W H YunArthur J Davidson
Sep 15, 2005·American Journal of Obstetrics and Gynecology·Judette M LouisTheodore B Jones
Jan 5, 2006·Acta Psychiatrica Scandinavica·M P FreemanA J Gelenberg
Feb 1, 2006·Journal of Community Health Nursing·Victoria Mosack, Elsie R Shore
Apr 28, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Brian Wells PenceBradley N Gaynes
Jan 17, 2007·Journal of Clinical Psychopharmacology·Margherita DalessandroJacopo Vecchiet
Apr 17, 2007·The Journal of Infectious Diseases·Deborah PersaudUNKNOWN Pediatric AIDS Clinical Trials Group P1030 Team
Jul 27, 2007·AIDS Patient Care and STDs·Ravi A MadanLisa L Dever
Dec 25, 2007·AIDS Patient Care and STDs·Jori A Berger-GreensteinTerence M Keane
Jun 11, 2008·Psychosomatic Medicine·Kathryn WhettenLaura Kathleen Murphy-McMillan
Feb 7, 2009·AIDS Patient Care and STDs·Suad KapetanovicAndrea Kovacs
Feb 1, 2003·Psychology, Health & Medicine·Gk Karimova, Cr Martin

❮ Previous
Next ❯

Citations

Jan 14, 2012·Obstetrics and Gynecology International·Doreen Matsui
Sep 19, 2015·The Journal of the Association of Nurses in AIDS Care : JANAC·Kate WillcocksRosalind Scourse
Jun 3, 2016·SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance·Karl PeltzerDeborah Jones
Aug 17, 2016·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·Sarah BuchanD William Cameron
Apr 7, 2020·Harvard Review of Psychiatry·Gustavo C MedeirosScott R Beach
Dec 2, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Angela KaidaDavid R Bangsberg
Mar 24, 2016·Reproductive Health·Heather BaileyUNKNOWN Ukraine European Collaborative Study in EuroCoord
Sep 29, 2018·The South African Journal of Psychiatry : SAJP : the Journal of the Society of Psychiatrists of South Africa·Puvashnee NydooJagidesa Moodley
Feb 2, 2019·BMC Pregnancy and Childbirth·Eugenia NyamukohoDixon Chibanda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.